Nefarious Trading
Equity Research · discord.gg/nfrs
Vol. 01 · No. 22
June 5, 2026
$MRLN $8.93 ▲ AFTER-HOURS +32.7% ▲ CDR COMPLETE · USSOCOM C-130J IDIQ CEILING $100M+ ▲ TD COWEN PT $11 ROTH PT $25 FY26 REV PROJECTED 2X YoY 52-WEEK LOW $5.78 ▼ CASH > DEBT $MRLN $8.93 ▲ AFTER-HOURS +32.7% ▲ CDR COMPLETE · USSOCOM C-130J IDIQ CEILING $100M+ ▲ TD COWEN PT $11 ROTH PT $25
Equity Research · Aerospace & Defense · Mid-Cap

Merlin Labs just passed its hardest test. The C-130J autonomy program is real — and the market hasn't priced it yet.

After 18 months of grinding from $14 IPO to a 52-week low of $5.78, Merlin Labs (NASDAQ: MRLN) cleared the Critical Design Review for its C-130J autonomy program with U.S. Special Operations Command on June 4. The stock gapped +32.7% in extended hours, from $7.18 to $9.49. The catalyst isn't a press release — it's validation that the architecture works. The IDIQ contract ceiling now sits above $100M, the program advances into integration and flight testing, and the company's "operating system of record for autonomous flight" thesis just got its first major government stamp.

Current Price
$8.93
After-hours June 4: $9.49 (+32.7%)
Market Cap
~$720M
Post-CDR repricing
IDIQ Ceiling
$100M+
C-130J USSOCOM program
FY26 Revenue
~2x
Wall Street consensus YoY
§ 01 — The Catalyst

What the Critical Design Review actually means. Not a press release — a milestone.

Defense technology programs live and die at gates. The Critical Design Review is the third major gate in the DoD acquisition lifecycle — it's the formal sign-off that the system architecture is mature enough to enter physical integration and test. Programs that pass CDR are the ones that get scaled. Programs that don't, get reshaped or cancelled. Merlin just passed for the C-130J autonomy stack.

The June 4 announcement reads as routine technical communication, but the substance is significant. CEO Matt George's statement that "Completing the Critical Design Review validates the architecture we've built for safe, scalable autonomy on large aircraft like the C-130J" describes what the milestone unlocks: the program now moves from design development into aircraft integration activities. That's the phase where Merlin's autonomy stack physically goes onto a C-130J Super Hercules — one of the most operationally critical airframes in the U.S. Special Operations toolkit — and undergoes ground testing, then flight demonstration.

For an aerospace autonomy company that IPO'd via SPAC less than a year ago, this is the milestone that separates "vendor with a pitch deck" from "vendor with a contract that can scale." The IDIQ structure (Indefinite Delivery, Indefinite Quantity) means the $100M+ ceiling isn't a fixed award — it's a procurement vehicle that the government can pull from as the program matures. Cleared CDR + IDIQ ceiling + aircraft integration phase = the runway for follow-on task orders that compound into the ceiling.

Why Critical Design Review matters: CDR is the final design configuration gate before metal-cutting. Programs that pass at this milestone have a structurally higher probability of reaching deployment. The reverse is also true — programs that fail CDR rarely recover. Merlin just crossed the dividing line between "speculative R&D contractor" and "operational defense vendor with active aircraft integration."

The market reaction tells you what institutions thought of the news. MRLN closed regular session June 4 at $7.18 — down 1.24% that day, sitting near a 52-week low of $5.78. The CDR announcement hit at 4:05 PM ET. Within hours, after-hours trading pushed shares to $9.49, a 32.7% gap. That's a re-rating, not a momentum chase. Institutional desks reassessed Merlin's risk profile in real time.

§ 02 — The Company

Merlin Labs in one paragraph. The operating system for autonomous flight.

Merlin is building the "operating system of record" for autonomous aircraft — military and civilian, from takeoff to touchdown. The flagship product, Merlin Pilot, is a full-stack autonomy system that integrates onto existing aircraft platforms rather than requiring new airframes. Their thesis is that the bottleneck for autonomous flight isn't the aircraft itself; it's the certified, mission-trusted software that controls it. Merlin builds that software.

Why USSOCOM Picked Merlin

U.S. Special Operations Command runs the most demanding tactical aviation in the U.S. military. Their C-130J operations include extreme low-altitude airdrops, short-field landings in contested environments, and around-the-clock crew-intensive missions. The autonomy thesis for SOCOM isn't replacing pilots — it's reducing crew workload so missions that currently require 4-person flight crews can be flown with reduced manning, freeing operators for the next sortie. The $100M+ IDIQ ceiling reflects what SOCOM is willing to invest to make that real.

The KC-135 Program

Merlin's C-130J program isn't the only government contract. The company also holds a contract for the KC-135 Stratotanker autonomy program, an air-refueling aircraft platform that's been in service since 1957 and remains the backbone of U.S. aerial refueling. Two of the most operationally critical legacy airframes in the DoD now have Merlin autonomy work on them. That's a defensible market position, not a one-program risk.

The Commercial Path

On May 14, 2026, Merlin announced Merlin Pilot for Commercial Cargo — an extension of the same autonomy stack into freight aviation. UAE expansion was announced via a teaming agreement with Remah International Group. The commercial cargo market is structurally underserved by autonomy compared to passenger aviation (less regulatory drag, less consumer perception risk), and aging cargo fleets need cockpit modernization. Merlin's same software, different aircraft platform.

§ 03 — The Numbers

Reading the balance sheet. Cash exceeds debt — that matters.

Most small-cap defense technology stocks have one fatal flaw: they burn cash faster than contracts deliver revenue, and they dilute equity to bridge the gap. Merlin's balance sheet is structurally different — InvestingPro data confirms the company holds more cash than debt obligations. That's a critical distinction for a sub-$1B market cap defense vendor sitting on a $100M+ contract ceiling.

Metric Value Source / Context
Current Price$8.93June 5, 2026 (after-hours $9.49)
52-Week Range$5.78 – $14IPO debut to recent low
Market Cap~$720MPost-CDR repricing
IDIQ Ceiling (C-130J)$100M+USSOCOM contract
FY26 Revenue Growth~2x YoYWall Street consensus
Cash vs DebtCash > DebtInvestingPro data
Employees125Lean operational footprint

Analyst Coverage

Firm Rating Target Implied Upside (from $8.93)
TD CowenBuy (initiated)$11+23%
Roth CapitalBuy (raised)$25+180%
Consensus High$25+180%
Consensus Low$11+23%

The analyst spread is wide — $11 to $25 — which tells you the buy-side has not yet reached consensus on how to value Merlin. Roth's $25 target was raised from $15, citing US government revenue concentration and program execution. TD Cowen initiated at $11 specifically calling out the C-130J and KC-135 programs. The CDR clears the way for both targets to be revisited upward.

§ 04 — The Thesis

Why MRLN matters now. Three structural tailwinds converging.

1. Defense AI Spend Is Accelerating

The June 2026 environment is the most aggressive defense AI procurement window in modern memory. The Trump administration's defense priorities have explicitly emphasized autonomous systems, AI-enabled platforms, and reduced manpower for routine sorties. The U.S.–Iran conflict that began in February 2026 has put operational pressure on existing crewed aviation — including the C-130J fleet that USSOCOM operates. Merlin's autonomy stack arrives at exactly the moment when "more capability with fewer pilots" stops being a budget pitch and starts being an operational necessity.

2. Aging Airframes Need New Software

The C-130J entered service in 1996. The KC-135 in 1957. The U.S. military operates hundreds of legacy aircraft that will not be retired anytime soon — too expensive to replace, too operationally critical to ground. The path forward for these airframes is software modernization. Merlin Pilot is purpose-built for that path: same airframe, autonomous cockpit, reduced crew. The TAM isn't just the C-130J — it's the entire long-tail of legacy military and commercial aircraft that can be retrofitted with full-stack autonomy.

3. The IDIQ Mechanism Is Underappreciated

The $100M+ IDIQ ceiling on the C-130J program is not the full opportunity. IDIQ ceilings are procurement caps, not minimum guarantees — but they're also re-negotiable upward as programs mature. Merlin's CDR completion is the structural event that makes the ceiling more likely to be drawn down meaningfully through task orders. Each task order is incremental revenue. The CDR doesn't unlock the $100M; it unlocks the right to compete for the task orders that compound into the $100M.

The structural setup: Merlin has now demonstrated technical maturity (CDR), commercial expansion (cargo aviation), international optionality (UAE), and balance sheet strength (cash > debt). That's the four-corner setup of a defense technology vendor that institutions can actually own. The June 4 move is the first step in a re-rating that has multi-quarter legs if execution holds.
§ 05 — The Risks

What could go wrong. Honest accounting of the bear case.

Bull Case

  • CDR validation Architecture passed the hardest design gate. Program transitions to integration phase with USSOCOM continued support.
  • $100M+ IDIQ ceiling Real procurement vehicle, not a press-release contract. Task orders unlock incremental revenue over time.
  • Cash > debt balance sheet Rare for sub-$1B defense vendor. Reduces near-term dilution risk.
  • FY26 revenue ~2x consensus Wall Street expects revenue to nearly double — gives a real growth anchor.
  • KC-135 + commercial cargo + UAE Multi-platform, multi-customer optionality. Not single-program risk.
  • Analyst PTs $11-$25 Even conservative target is +23% from here. Bull case is +180%.

Bear Case

  • SPAC origin + recent IPO Merlin debuted via SPAC. Lock-up expirations and insider selling pressure are real risks over the next 6-12 months.
  • Concentration risk Most revenue comes from US government contracts. Budget cycles or program reprioritization could disrupt the trajectory.
  • Integration phase ≠ flight test CDR is a design gate. The next gate is ground testing, then flight demonstration. Either could surface issues.
  • The +32% gap is unwound risk Stocks that gap +32% on news often retrace 30-50% of the move in the first 5 trading days. Patience on entry.
  • 125 employees Small team. Scaling execution across multiple programs simultaneously is operationally hard.
  • Roth $25 target is aspirational Most likely path is the TD Cowen $11 range, not the Roth high. Don't anchor on the highest number.
§ 06 — Price Targets

Where this could go. Three scenarios, three timelines.

Conservative · 3-6mo
$11
TD Cowen target. Re-rating to analyst consensus on continued program execution. +23% from current.
Base Case · 6-12mo
$15
CDR validation + first task order draws + commercial cargo announcements. +68% from current.
Bull Case · 12-24mo
$25
Roth Capital high target. Multi-program execution + IDIQ ceiling drawn down + commercial revenue ramp. +180% from current.

The three-scenario ladder reflects how I'm sizing exposure. Below $11 is the conservative case where MRLN simply re-rates to the floor of the analyst range. Below $15 is where program execution starts compounding — task orders against the IDIQ ceiling, KC-135 milestones, commercial cargo design wins. Above $15 to $25 is the multi-year structural case where Merlin becomes a real defense technology platform, not a single-program vendor.

How to manage the entry: The +32.7% gap from $7.18 to $9.49 in after-hours is unwound risk for the first 3-5 sessions. Patient entries between $7.50–8.50 are likely to fill as the gap consolidates. Chasing above $9.50 on day-one momentum is the worst risk/reward — the same pattern that took CRWV from $124 back to $108 in five sessions. Wait for the structure to confirm before adding.
§ 07 — My Position

Disclosure and trade plan. I've been long since the $7s and adding.

I've held 550 shares of MRLN with an average cost basis around $8.50 — a position that was meaningfully red before the June 4 CDR catalyst. The aerospace and defense basket in my book also includes IRDM (satellite communications) and PNG (defense imaging). MRLN was the highest-conviction speculative leg of that basket and the one bleeding the most before this catalyst.

My plan from here:

  • Hold the existing 550 shares. Cost basis is now in the green after the gap. No reason to trim until $11 (TD Cowen target).
  • Watch for the gap fill. If MRLN retraces toward $7.50-8.00 in the next 5 sessions, I'll consider adding 100-200 shares.
  • Trim 1/3 at $11, 1/3 at $15, hold runners past $20. Same trim ladder we used on HLIT — protect the gains, let the multi-year thesis compound on the rest.
  • Catalyst stack to watch: KC-135 program milestones, first task order draws against the IDIQ ceiling, commercial cargo design wins, Jefferies Defense Tech Summit (June 4), ROTH London Conference, Maxim Defense Tech Conference.

The Nefarious verdict. This is what the aerospace defense thesis looks like working.

Merlin Labs cleared the Critical Design Review for its C-130J autonomy program with U.S. Special Operations Command on June 4, gapping +32.7% in extended hours and re-rating from $7.18 to $9.49. The catalyst is structural, not headline-driven. The architecture has been validated, the program enters integration phase, the IDIQ ceiling is real, the balance sheet supports continued operations without dilution, and Wall Street expects revenue to nearly double in FY26. Analyst price targets span $11 to $25 from a current price of $8.93. The risks are real — SPAC origins, government concentration, integration-phase execution — but the structural setup now favors patient capital. I'm holding and adding on the gap fill, not chasing the spike.

Position
Long
Conviction
High
Timeline
6-24mo

"The companies that pass CDR are the ones that scale. Merlin just crossed the line."